ResultsIQ

ResultsIQ › Latest results › Natural Capsules Limited

Natural Capsules Limited Q1 FY26 results deck summary

NSE: NATCAPSUQ · BSE: 524654

Results deck of 5 Aug 2025, summarised by AI from the filing.

Q1FY26 revenue rose 15.36% Y-o-Y to ₹45.20 cr, but PAT fell to a ₹5.58 cr loss after API facility capitalisation expenses.

Key takeaways

  1. Q1FY26 revenue Revenue from operations was ₹45.20 cr, up 15.36% Y-o-Y from ₹39.18 cr and 0.52% Q-o-Q from ₹44.97 cr.
  2. API breakeven Management targets average cash breakeven at the API facility for the first full year of operations.
  3. HPMC demand US duties on Chinese HPMC capsules continue to create demand for Indian manufacturers, with healthy enquiries.
  4. Margin pressure EBITDA margin fell to 0.71% in Q1FY26 from 11.14% in Q1FY25 and 9.74% in Q4FY25.

Original filing on BSE

Natural Capsules Limited Q1 FY27 results

As filed: Revenue ₹48.7 cr (+8% year on year), EBITDA ₹1.1 cr (+12% year on year), PAT −₹5.7 cr, EBITDA margin 2.3% (+8 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹58.5 cr (+30% year on year), EBITDA ₹1.3 cr (−73% year on year), PAT −₹5.0 cr (−300% year on year), EBITDA margin 2.3% (−884 bps). Score 20 of 100, Below trend. EBITDA margin fell 884 bps year on year. Consolidated profit -598% but standalone +84%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −6.5% in 29 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹34.2 cr, EBITDA ₹1.9 cr, PAT ₹0.4 cr, EBITDA margin 5.5%. Not scored. No result for the same quarter last year. Share price after the results: −10.5% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹45.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.1%. Not scored. No result for the same quarter last year. Share price after the results: −11.6% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹44.0 cr, EBITDA ₹4.0 cr, PAT ₹3.0 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹44.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.4%. Not scored. No result for the same quarter last year. Share price after the results: −2.2% in 29 days (Nifty 500: +3.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Natural Capsules Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.